QDEL: QuidelOrtho Corporation Stock

by  •  • Comments Off on QDEL: QuidelOrtho Corporation Stock

SIC 2835 – In Vitro and In Vivo Diagnostic Substances

Valuation
Market Cap ($M) 2,764.25
Enterprise Value ($M) 5,400.95
Book Value ($M) 3,186.70
Book Value / Share 47.38
Price / Book 0.87
NCAV ($M) -2,201.80
NCAV / Share -32.74
Price / NCAV -1.26

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.22
Return on Equity (ROE) -0.37

Liquidity (mrq)
Quick Ratio 0.81
Current Ratio 1.38

Balance Sheet (mrq) ($M)
Current Assets 1,412.60
Assets 6,801.10
Liabilities 3,614.40
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
12-06 13G/A Vanguard Group Inc 10.13 12.67
11-21 13D/A Carlyle Group Inc. 0.00 -100.00
11-14 13G/A T. Rowe Price Investment Management, Inc. 14.00 8.05
11-13 13G Rubric Capital Management LP 6.25
10-07 13G/A BlackRock, Inc. 10.80

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-15 156,407 1,056,097 14.81
2025-01-14 252,067 1,457,619 17.29
2025-01-13 225,695 1,107,254 20.38
2025-01-10 174,376 859,675 20.28

(click for more detail)

Similar Companies
PRTA – Prothena Corporation plc PTCT – PTC Therapeutics, Inc.
PYXS – Pyxis Oncology, Inc. QNCX – Quince Therapeutics, Inc.
QURE – uniQure N.V.


Financial data and stock pages provided by
Fintel.io